These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14273321)

  • 1. COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES.
    COHEN AA; HALE FC
    Am J Med Sci; 1965 Mar; 249():309-15. PubMed ID: 14273321
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of isoproterenol and isoproterenol-phenylephrine aerosols.
    Grant JL; Werfelman N; Cook MR; Metherall W
    Chest; 1971 Aug; 60(2):129-32. PubMed ID: 5571471
    [No Abstract]   [Full Text] [Related]  

  • 3. PULMONARY FUNCTION AND THERAPY IN DISABILITY APPLICANTS.
    SILVER HM
    JAMA; 1965 Mar; 191():1059-63. PubMed ID: 14261886
    [No Abstract]   [Full Text] [Related]  

  • 4. VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.
    ALTOUNYAN RE
    Thorax; 1964 Sep; 19(5):406-15. PubMed ID: 14216969
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC; Clément J; Van de Woestijne KP
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [No Abstract]   [Full Text] [Related]  

  • 6. Bronchial component in chronic obstructive lung disease.
    Ayres SM; Griesbach SJ; Reimold F; Evans RG
    Am J Med; 1974 Aug; 57(2):183-91. PubMed ID: 4843892
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the respiratory effects of SCH-13949W and isoproterenol aerosols in the treatment of patients with expiratory airflow disorders. Preliminary analysis in a long-term trial in ambulatory patients.
    Cohen BM
    Postgrad Med J; 1971 Mar; 47():Suppl:63-71. PubMed ID: 4929396
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P; Sentissi M
    Postgrad Med J; 1971 Mar; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract]   [Full Text] [Related]  

  • 9. Total pulmonary and airway resistances as measures of the relief of bronchospasm.
    Cohen BM
    Int Surg; 1969 Dec; 52(6):444-50. PubMed ID: 4900766
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of methacholine-induced bronchoconstriction in patients with chronic obstructive pulmonary disease.
    Greenspon LW; Parrish B
    Am Rev Respir Dis; 1988 Feb; 137(2):281-5. PubMed ID: 3277497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.
    FREEDMAN BJ
    Br Med J; 1963 Dec; 2(5371):1509-12. PubMed ID: 14063078
    [No Abstract]   [Full Text] [Related]  

  • 12. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
    el-Naggar M; Collins VJ
    Crit Care Med; 1974; 2(2):82-5. PubMed ID: 4832285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Spirometry].
    Schlegel J
    Verh Dtsch Ges Inn Med; 1990; 96():713-9. PubMed ID: 2092511
    [No Abstract]   [Full Text] [Related]  

  • 14. Frequency dependence of pulmonary compliance and resistance in patients with mild and severe chronic obstructive lung disease.
    Bobbaers H; Demedts M; De Sutter P; Van de Woestijne KP
    Bull Physiopathol Respir (Nancy); 1971; 7(2):425-31. PubMed ID: 5112104
    [No Abstract]   [Full Text] [Related]  

  • 15. BRONCHODILATING EFFECT OF BRONTINE AND ISOPRENALINE. ADDITIVE ACTION OF ISOPRENALINE INHALATION RESPECTIVE EPINEPHRINE INJECTION.
    SIMONSSON BG
    Med Thorac; 1964; 21():295-302. PubMed ID: 14265982
    [No Abstract]   [Full Text] [Related]  

  • 16. COMPREHENSIVE THERAPY OF OBSTRUCTIVE PULMONARY DISEASE.
    LEVY D
    Isr Med J; 1964; 23():97-105. PubMed ID: 14197008
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between R t and FEV 1.0 before and after inhalation of isoproterenol in patients with chronic obstructive syndrome.
    Stadeler HJ; Ferlinz R; Del Valle-Monge J
    Bull Physiopathol Respir (Nancy); 1971; 7(3):555-9. PubMed ID: 5119275
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in airway dynamics following inhalation of ultrasonic mist.
    Malik SK; Jenkins DE
    Chest; 1972 Dec; 62(6):660-4. PubMed ID: 4635412
    [No Abstract]   [Full Text] [Related]  

  • 19. Bronchodilator therapy: comparison of acute response to three methods of administration.
    Chester EH; Racz I; Barlow PB; Baum GL
    Chest; 1972 Oct; 62(4):394-9. PubMed ID: 4562180
    [No Abstract]   [Full Text] [Related]  

  • 20. TREATMENT AND TREATMENT METHODS IN THE CHRONIC BRONCHITIS PULMONARY EMPHYSEMA SYNDROME.
    HALE FC; COHEN AA
    Tuberculol Thorac Dis; 1964 Dec; 22():38-43. PubMed ID: 14236471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.